Skip to main content
. 2011 Jul 12;6(7):e22203. doi: 10.1371/journal.pone.0022203

Figure 5. Kaplan-Meier survival curves illustrating the significance of TSP50 expression in comparison with CEA expression in CRC.

Figure 5

(A) Overall, CRC patients with high TSP50 expression had shorter CRC-specific survival than those with low TSP50 expression (log-rank P = 0.010); (B) High CEA expression was associated significantly with poor CRC-specific survival relative to low CEA expression (log-rank P = 0.013); (C) In early-stage CRC (stage I and II), patients with high TSP50 expression had a significantly reduced CRC-specific survival relative to those with low expression (log-rank P = 0.004); (D) There was no significant difference between low and high expression of TSP50 in patients with advanced-stage CRC (stage III and IV; log-rank P = 0.274).